Showing results (61-70 of 577) with videos related to
Sort By:
Pageof 58
Cancer|July 13, 2002
7-Hydroxytryptophan, a novel, specific, cytotoxic agent for carcinoids and other serotonin-producing tumorsDiego J Walther, Jens-Uwe Peter, Michael BaderTransgenic Research|June 5, 2008
Generation and characterization of a GFP transgenic rat line for embryological researchElena Popova, Brit Rentzsch, Michael Bader, et al.Gene|May 25, 2015
Multiple non-coding exons and alternative splicing in the mouse Mas protooncogeneNatalia Alenina, Ilka Böhme, Michael Bader, et al.CNS Neuroscience & Therapeutics|January 19, 2016
Locus Coeruleus Dysfunction in Transgenic Rats with Low Brain AngiotensinogenMichael Ogier, Giampiero Bricca, Michael Bader, et al.Cells|March 10, 2022
Tph2 Gene Expression Defines Ethanol Drinking Behavior in MiceMagdalena Zaniewska, Valentina Mosienko, Michael Bader, et al.Analytical Methods : Advancing Methods and Applications|October 27, 2022
Reliable determination of the main metabolites of 2-phenoxyethanol in human blood and urine using LC-MS/MS analysisThomas Jäger, Elisabeth Eckert, Edgar Leibold, et al.Peptides|July 24, 2007
Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodelingHang Yin, Julie Chao, Michael Bader, et al.Archives of Toxicology|November 15, 2006
Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditionsMichael Bader, Renate Wrbitzky, Meinolf Blaszkewicz, et al.Expert Opinion on Emerging Drugs|September 13, 2011
Emerging drugs which target the renin-angiotensin-aldosterone systemUlrike Muscha Steckelings, Ludovit Paulis, Thomas Unger, et al.Industrial Health|August 17, 2005
Longitudinal study to explore chronic neuropsychologic effects on solvent exposed workersAndreas Ihrig, Michael C Dietz, Michael Bader, et al.Pageof 58